Clinical trial
Multi-omics Studies of Primary Aldosteronism
NCT07111351 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-omics Studies of Primary Aldosteronism
- Lead sponsor
- Peking University First Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 15, 2025
- Completion date
- May 31, 2029
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary aldosteronism